title: Methemoglobin Formation and Characterization of Hemoglobin Adducts of Carcinogenic Aromatic Amines and Heterocyclic Aromatic Amines.
abstract: Arylamines (AAs) and heterocyclic aromatic amines (HAAs) are structurally related carcinogens formed during the combustion of tobacco or cooking of meat. They undergo cytochrome P450 mediated N-hydroxylation to form metabolites which bind to DNA and lead to mutations. The N-hydroxylated metabolites of many AAs also can undergo a co-oxidation reaction with oxy-hemolgobin (HbO2) to form methemoglobin (met-Hb) and the arylnitroso intermediates, which react with the β-Cys(93) chain of Hb to form Hb-arylsulfinamide adducts. The biochemistry of arylamine metabolism has been exploited to biomonitor certain AAs through their Hb arylsulfinamide adducts in humans. We examined the reactivity of HbO2 with the N-hydroxylated metabolites of 4-aminobiphenyl (ABP, HONH-ABP), aniline (ANL, HONH-ANL), and the HAAs 2-amino-9H-pyrido[2,3-b]indole (AαC, HONH-AαC), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP, HONH-PhIP), and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx, HONH-MeIQx). HONH-ABP, HO-ANL, and HONH-AαC induced methemoglobinemia and formed Hb sulfinamide adducts. However, HONH-MeIQx and HONH-PhIP did not react with the oxy-heme complex, and met-Hb formation and chemical modification of the β-Cys(93) residue were negligible. Molecular modeling studies showed that the distances between the H-ON-AA or H-ON-HAA substrates and the oxy-heme complex of HbO2 were too far away to induce methemoglobinemia. Different conformational changes in flexible helical and loop regions around the heme pocket induced by the H-ON-AA or H-ON-HAAs may explain the different proclivities of these chemicals to induce methemoglobinemia. Hb-Cys(93β) sulfinamide and sulfonamide adducts of ABP, ANL, and AαC were identified, by Orbitrap MS, following the proteolysis of Hb with trypsin, Glu-C, or Lys-C. Hb sulfinamide and sulfonamide adducts of ABP were identified in the blood of mice exposed to ABP, by Orbitrap MS. This is the first report of the identification of intact Hb sulfinamide adducts of carcinogenic AAs in vivo. The high reactivity of HONH-AαC with HbO2 suggests that the Hb sulfinamide adduct of AαC may be a promising biomarker of exposure to this HAA in humans.
authors.affiliation: Masonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Khyatiben V
authors.initials: KV
authors.lastname: Pathak
authors.affiliation: Masonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Ting-Lan
authors.initials: TL
authors.lastname: Chiu
authors.affiliation: Masonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Elizabeth Ambrose
authors.initials: EA
authors.lastname: Amin
authors.affiliation: Masonic Cancer Center and ‡Department of Medicinal Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Turesky
mesh_terms: D000588:Amines / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D002273:Carcinogens / Q000737:chemistry / Q000378:metabolism*; D006454:Hemoglobins / Q000737:chemistry / Q000378:metabolism*; D006571:Heterocyclic Compounds / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D006841:Hydrocarbons, Aromatic / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D008706:Methemoglobin / Q000737:chemistry / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains
chemical_list: D000588:Amines; D002273:Carcinogens; D006454:Hemoglobins; D006571:Heterocyclic Compounds; D006841:Hydrocarbons, Aromatic; D008706:Methemoglobin
references.citation: J Mol Biol. 1996 Mar 8;256(4):775-92
references.pmid: 8642597
references.citation: Proc Natl Acad Sci U S A. 1988 Dec;85(24):9788-91
references.pmid: 3200858
references.citation: Environ Health Perspect. 2002 Feb;110 Suppl 1:3-9
references.pmid: 11834459
references.citation: Anal Bioanal Chem. 2015 Sep;407(22):6627-35
references.pmid: 26105512
references.citation: Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700
references.pmid: 2813353
references.citation: Biochem Pharmacol. 1989 Oct 15;38(20):3511-9
references.pmid: 2818643
references.citation: J Org Chem. 2007 Jun 22;72(13):4698-706
references.pmid: 17542636
references.citation: FEBS Lett. 1997 Jan 2;400(1):19-24
references.pmid: 9000506
references.citation: J Mass Spectrom. 2003 Nov;38(11):1143-9
references.pmid: 14648821
references.citation: Anal Chem. 2013 Jan 15;85(2):1065-72
references.pmid: 23240913
references.citation: Environ Health Perspect. 1993 Mar;99:213-6
references.pmid: 8319626
references.citation: J Natl Cancer Inst. 2001 Apr 4;93(7):538-45
references.pmid: 11287448
references.citation: J Mass Spectrom. 2008 Nov;43(11):1470-81
references.pmid: 18457351
references.citation: Exp Biol Med (Maywood). 2007 Mar;232(3):437-44
references.pmid: 17327478
references.citation: Chem Res Toxicol. 2012 Oct 15;25(10):2179-93
references.pmid: 22827630
references.citation: Cancer Lett. 1999 Sep 1;143(2):149-55
references.pmid: 10503895
references.citation: Carcinogenesis. 1991 Oct;12(10):1839-45
references.pmid: 1934265
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):507-12
references.pmid: 10385140
references.citation: Pharmacol Rev. 1966 Sep;18(3):1091-161
references.pmid: 5343079
references.citation: Carcinogenesis. 2002 May;23(5):831-8
references.pmid: 12016157
references.citation: Carcinogenesis. 1991 Jun;12(6):1067-72
references.pmid: 2044186
references.citation: Methods Enzymol. 1994;231:643-9
references.pmid: 8041282
references.citation: Carcinogenesis. 2004 Sep;25(9):1659-69
references.pmid: 15073045
references.citation: Biochemistry. 2005 Jun 14;44(23):8347-59
references.pmid: 15938624
references.citation: Carcinogenesis. 1999 Mar;20(3):353-68
references.pmid: 10190547
references.citation: Proc Natl Acad Sci U S A. 1981 Apr;78(4):2003-7
references.pmid: 6941266
references.citation: Rapid Commun Mass Spectrom. 2002;16(9):871-8
references.pmid: 11948819
references.citation: Chem Res Toxicol. 1998 Aug;11(8):925-36
references.pmid: 9705755
references.citation: J Comput Chem. 2008 Jul 30;29(10):1693-8
references.pmid: 18307169
references.citation: Sci Am. 1978 Dec;239(6):92-125
references.pmid: 734439
references.citation: Chem Res Toxicol. 2003 Sep;16(9):1162-73
references.pmid: 12971805
references.citation: Eur J Biochem. 1972 Aug 4;28(4):533-7
references.pmid: 5081611
references.citation: J Biol Chem. 1964 May;239:1474-84
references.pmid: 14189881
references.citation: Mutat Res. 1997 May 12;376(1-2):153-60
references.pmid: 9202751
references.citation: Cancer Res. 1970 Mar;30(3):559-76
references.pmid: 4915745
references.citation: Chem Biol Interact. 1992 Jan;81(1-2):91-117
references.pmid: 1730150
references.citation: J Phys Chem B. 2013 Aug 29;117(34):9831-9
references.pmid: 23902424
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
references.pmid: 15285078
references.citation: Cancer Sci. 2004 Apr;95(4):290-9
references.pmid: 15072585
references.citation: Mutat Res. 2002 Sep 30;506-507:21-8
references.pmid: 12351141
references.citation: Cancer Res. 1991 Oct 1;51(19):5284-91
references.pmid: 1913651
references.citation: Drug Metab Dispos. 1998 Aug;26(8):825-8
references.pmid: 9698300
references.citation: Cancer Lett. 1980 Aug;10(2):141-9
references.pmid: 7006799
references.citation: ACS Chem Biol. 2014 Oct 17;9(10):2318-25
references.pmid: 25061917
references.citation: Biochemistry. 1962 Sep;1:735-8
references.pmid: 13967411
references.citation: Toxicol Lett. 2012 Aug 13;213(1):83-90
references.pmid: 21501670
references.citation: Acta Crystallogr A. 1992 Jan 1;48 ( Pt 1):11-4
references.pmid: 1550663
references.citation: Nicotine Tob Res. 2011 Feb;13(2):120-6
references.pmid: 21173043
references.citation: Chem Res Toxicol. 1998 Mar;11(3):217-25
references.pmid: 9544620
references.citation: Mol Cell Proteomics. 2012 Mar;11(3):M111.013185
references.pmid: 22171319
references.citation: Chem Res Toxicol. 1988 Jan-Feb;1(1):22-4
references.pmid: 2979706
references.citation: J Natl Cancer Inst. 2004 Oct 6;96(19):1425-31
references.pmid: 15467031
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Oct 5;778(1-2):279-308
references.pmid: 12376136
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7
references.pmid: 12814994
references.citation: Chem Res Toxicol. 2011 Aug 15;24(8):1169-214
references.pmid: 21688801
references.citation: Chem Res Toxicol. 2012 Oct 15;25(10):2007-35
references.pmid: 22827593
references.citation: J Proteome Res. 2007 Feb;6(2):654-61
references.pmid: 17269722
references.citation: J Mol Biol. 2006 Jul 14;360(3):690-701
references.pmid: 16765986
references.citation: Biophys J. 2006 Jun 15;90(12):4558-73
references.pmid: 16565070
references.citation: J Biol Chem. 2015 Jun 26;290(26):16304-18
references.pmid: 25953894
references.citation: Carcinogenesis. 2000 Jul;21(7):1347-54
references.pmid: 10874013
references.citation: Carcinogenesis. 1990 Apr;11(4):507-18
references.pmid: 2182215
references.citation: Rapid Commun Mass Spectrom. 1999;13(18):1833-7
references.pmid: 10482897
references.citation: Cancer Res. 2006 Nov 1;66(21):10541-7
references.pmid: 17079477
references.citation: Cancer Res. 1989 Jan 1;49(1):25-31
references.pmid: 2908851
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 1;878(27):2474-82
references.pmid: 20471333
references.citation: Proteins. 1999 May 15;35(3):275-82
references.pmid: 10328262
references.citation: Int Arch Occup Environ Health. 1988;60(3):151-5
references.pmid: 3384479
references.citation: Chem Commun (Camb). 2010 Dec 14;46(46):8827-9
references.pmid: 20953479
references.citation: J Comput Aided Mol Des. 2012 Jun;26(6):775-86
references.pmid: 22566074
references.citation: Environ Pollut. 1991;70(3):255-65
references.pmid: 15092136
references.citation: Eur J Biochem. 1992 May 15;206(1):103-7
references.pmid: 1587264
references.citation: Cancer Res. 1987 Jan 15;47(2):602-8
references.pmid: 3791245
references.citation: Mass Spectrom Rev. 2009 Sep-Oct;28(5):725-84
references.pmid: 19127566
references.citation: Arch Toxicol. 1984 Nov;56(1):1-6
references.pmid: 6517706
references.citation: Biophys Chem. 2007 May;127(3):181-93
references.pmid: 17350155
references.citation: Drug Metab Rev. 1994;26(1-2):111-24
references.pmid: 8082561
references.citation: J Biol Chem. 1965 Jan;240:PC551-2
references.pmid: 14253474
references.citation: Cancer Res. 1984 Oct;44(10):4254-9
references.pmid: 6467185
references.citation: Princess Takamatsu Symp. 1995;23:154-62
references.pmid: 8844806
references.citation: Clin Chem. 1991 Sep;37(9):1633-8
references.pmid: 1716537
references.citation: Carcinogenesis. 1988 Nov;9(11):2003-8
references.pmid: 2846195
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1976;292(1):59-66
references.pmid: 934354